Clinical Trial for Dogs with Recurrent Staphylococcal Skin Infections
This study is currently on hold and not recruiting patients. Please check back soon for updates. Thank you.
A new clinical trial is ongoing for dogs with recurrent pyoderma, defined as those with three or more episodes of staphylococcal skin infection in the last six months. The infections can be related to known underlying causes such as allergies, or to unknown causes.
The Dermatology Service at UW Veterinary Care is investigating the effectiveness of a new staphylococcal vaccine product. The product is intended to prevent recurrent skin infections, helping alleviate the need for repeated courses of antibiotics.
In addition to having at least three episodes of infection in the last 6 months, eligible dogs must have had causes such as hypothyrodism, parasites or food allergies ruled out or under control. Clients must pay for the initial exam, but if the dog qualifies for entry into the trial, all further charges (including followup visits, diagnostic evaluations, cultures, a complete series of blood and allergy tests, and medication costs) will be paid by the study. The trial for each dog will last approximately 18 weeks, with visits to UW Veterinary Care every six weeks. The clinical trial will be double blinded and placebo controlled.